金浦鈦業(000545.SZ)一字跌停 此前7連板
格隆匯11月24日丨此前連續走出7個漲停板的金浦鈦業(000545.SZ)今日一字跌停,報4.15元,暫成交逾1億元,跌停封單近6萬手,最新市值41億元。主營鈦白粉生產和銷售的金浦鈦業11月18日公告顯示“增資供應鏈 削商業保理”:公司分別對全資子公司南京金浦供應鏈管理有限公司進行增資,對全資子公司南京金浦商業保理有限公司進行減資。值得注意的是,公司今年前三季度業績大幅下滑,淨利潤為-5348.44萬元,同比下降201.93%,扣非淨利潤為-6461.03萬元,同比下降260.41%,公司的銷售毛利率也降到9.20%,同比下降47.37%。有分析人士稱,金浦鈦業增資供應鏈以作業績“回春之術”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.